Overall, AML is characterized by the presence of gene mutations encoding gene expression regulators, like MLL-AF9 fusion gene that disrupts expression of the genes regulating hematopoietic stem cells self-renewal, differentiation and survival [18]. Here, KMT2A is linked to acute myeloid leukemia.